- Remove All
Your shopping cart is currently empty
Ceruletide is a decapeptide that serves as a safe and effective cholecystokinin receptor agonist, exerting a direct spasmogenic effect on the gallbladder muscle and bile ducts, and is commonly used to establish pancreatitis models.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μg | $31 | In Stock | |
| 500 μg | $56 | In Stock | |
| 1 mg | $89 | In Stock | |
| 5 mg | $347 | In Stock | |
| 10 mg | $538 | In Stock | |
| 25 mg | $856 | In Stock | |
| 50 mg | $1,150 | In Stock |
| Description | Ceruletide is a decapeptide that serves as a safe and effective cholecystokinin receptor agonist, exerting a direct spasmogenic effect on the gallbladder muscle and bile ducts, and is commonly used to establish pancreatitis models. |
| Targets&IC50 | mice:1012 mg/kg (LD50) |
| In vitro | Ceruletide is biologically and chemically identical to the human gastrointestinal hormones cholecystokinin-pancreatin (CCK) and gastrin II;Ceruletide stimulates gallbladder contraction while delaying gastric emptying and inhibiting motility of the proximal duodenum [1]. Ceruletide activates NF-κB/Rel in vitro at high doses (but not physiological doses), which may induce a self-defense gene program before cell damage occurs and may protect pancreatic acinar cells from further damage after secretagogue overstimulation [2]. |
| In vivo | Ceruletide (5-15 ng/kg intravenously) has a significant spasmodic effect on the pylorus in rats[1]; Ceruletide (0.4-0.5 mcg/kg intravenously; 3-4 mcg/kg subcutaneously) causes vomiting and defecation in conscious dogs [3]. |
| Disease Modeling Protocol | Establishment of chronic pancreatitis model
*Precautions: Three days after the last cerulein injection, mice were sacrificed and pancreatic tissue samples were collected for observation. |
| Synonyms | FI-6934, Cerulein, Caerulein |
| Molecular Weight | 1352.4 |
| Formula | C58H73N13O21S2 |
| Cas No. | 17650-98-5 |
| Smiles | CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |
| Relative Density. | 1.406g/cm3 |
| Sequence | {pGlu}-Gln-Asp-Tyr(SO3H)-Thr-Gly-Trp-Met-Asp-Phe-NH2 |
| Sequence Short | {pGlu}-QD-Y(SO3H)-TGWMDF-NH2 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 255 mg/mL (188.55 mM), Sonication is recommended. H2O: 5 mg/mL (3.7 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.